{"id":51812,"date":"2023-09-20T09:25:29","date_gmt":"2023-09-20T09:25:29","guid":{"rendered":"https:\/\/medsname.com\/nebicard\/"},"modified":"2026-08-28T11:46:17","modified_gmt":"2026-08-28T11:46:17","slug":"nebicard","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/nebicard\/","title":{"rendered":"Nebicard"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 0 0 24px 0; border-radius: 4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin: 0 0 8px 0; font-size: 16px; font-weight: bold;\">\u26a1 Quick Answer \u2014 What is Nebicard?<\/h3>\n<p style=\"margin: 0;\"><strong>Nebicard<\/strong> este un <strong>Comprimate de nebivolol 2,5 mg \/ 5 mg<\/strong> from Torrent Pharmaceuticals \u2014 ultra-selective beta-1 blocker with additional nitric-oxide-mediated vasodilation. Primary use is <strong>hipertensiunea arterial\u0103<\/strong>; utilizat \u0219i pentru angin\u0103, controlul aritmiilor, preven\u021bia secundar\u0103 post-infarct miocardic. Preferat la pacien\u021bii v\u00e2rstnici, cu sindrom metabolic \u0219i pacien\u021bi cu disfunc\u021bie erectil\u0103. Doz\u0103 tipic\u0103 pentru hipertensiune: <strong>5 mg o dat\u0103 pe zi (interval 2,5-10 mg). \u00cencepe\u021bi cu 2,5 mg la persoanele \u00een v\u00e2rst\u0103 sau cu insuficien\u021b\u0103 renal\u0103.<\/strong> Contraindicated la <strong>astm (relativ pentru agen\u021bii cardioselectivi; absolut pentru cele neselective), bradicardie sever\u0103, bloc cardiac de gradul doi\/trei, insuficien\u021b\u0103 cardiac\u0103 acut\u0103 decompensat\u0103 \u0219i feocromocitom\u0103 f\u0103r\u0103 blocare alfa prealabil\u0103<\/strong>. Do NOT stop abruptly \u2014 taper over 1-2 weeks to avoid rebound tachycardia \/ angina \/ MI.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate \u00een \u00eentreaga lume \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 nume de medicament pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesator reglementat (descrierile de pe extrasul de cont includ un procesator de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau nume de medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este acoperit\u0103 de Politica noastr\u0103 de Asigurare pentru Retrimitere.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Nebicard?<\/h2>\n<p>Nebicard este un comprimat oral care con\u021bine <strong>nebivolol 2,5 mg \/ 5 mg<\/strong> de la Torrent Pharmaceuticals, furnizat \u00een cutii de 30-180 comprimate. Nebivololul este un blocant beta-1 ultra-selectiv cu vasodilata\u021bie suplimentar\u0103 mediat\u0103 de oxid nitric. Blocant beta de genera\u021bia a treia cu <strong>cea mai mare selectivitate beta-1 dintre toate agen\u021bii utiliza\u021bi clinic<\/strong> (roughly 10\u00d7 more selective than bisoprolol) and a unique property: it releases nitric oxide in the vascular endothelium, producing direct vasodilation. Evidence from the <strong>SENIORS<\/strong> for elderly heart failure (heart failure with preserved ejection fraction included \u2014 unusual for a beta-blocker).<\/p>\n<h2 class=\"wp-block-heading\">Cum Nebivololul scade tensiunea arterial\u0103<\/h2>\n<p>Beta-blocantele reduc tensiunea arterial\u0103 prin patru mecanisme:<\/p>\n<ul>\n<li><strong>Reducerea debitului cardiac<\/strong> \u2014 beta-1 blockade in the sinoatrial node reduces heart rate, and blockade in ventricular myocardium reduces contractility. Lower cardiac output = lower blood pressure.<\/li>\n<li><strong>Suprimarea sistemului renin\u0103-angiotensin\u0103<\/strong> \u2014 beta-1 blockade in juxtaglomerular cells reduces renin release, lowering angiotensin II and aldosterone over 2-4 weeks. This accounts for much of the long-term BP effect.<\/li>\n<li><strong>Reducerea simpaticului central<\/strong> \u2014 lipophilic beta-blockers cross the blood-brain barrier and reduce central sympathetic outflow.<\/li>\n<li><strong>Vasodilata\u021bie mediat\u0103 de oxid nitric<\/strong> (nebivolol-specific) \u2014 endothelial NO release produces direct arterial relaxation alongside the beta-blockade effect.<\/li>\n<\/ul>\n<p>Beta-blocantele sunt <strong>moderat lipofil<\/strong>. Timpul de \u00eenjum\u0103t\u0103\u021bire plasmatic al nebivololului este de 10-44 de ore (\u00een func\u021bie de statutul de metabolizor).<\/p>\n<h2 class=\"wp-block-heading\">Utiliz\u0103ri aprobate \u0219i bazate pe dovezi<\/h2>\n<ul>\n<li><strong>Hipertensiune arterial\u0103<\/strong> (indica\u021bie principal\u0103)<\/li>\n<li><strong>Insuficien\u021b\u0103 cardiac\u0103 la v\u00e2rstnici<\/strong> (&gt;70 years) \u2014 SENIORS evidence<\/li>\n<li><strong>Hipertensiune arterial\u0103 cu sindrom metabolic<\/strong> \u2014 favourable on glucose\/lipid profile vs older beta-blockers<\/li>\n<li><strong>Hipertensiune arterial\u0103 la pacien\u021bii cu disfunc\u021bie erectil\u0103<\/strong> \u2014 less sexual-dysfunction impact than propranolol \/ atenolol; in some studies, improved endothelial function improves erectile function<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Doza Nebicard<\/h2>\n<p><strong>Doza pentru hipertensiune arterial\u0103 la adul\u021bi:<\/strong> 5 mg o dat\u0103 pe zi (interval 2,5-10 mg). \u00cencepe\u021bi cu 2,5 mg la persoanele \u00een v\u00e2rst\u0103 sau cu insuficien\u021b\u0103 renal\u0103.<\/p>\n<p>Start low, titrate upward over 2-4 weeks to target BP (typically &lt;140\/90 in uncomplicated hypertension; &lt;130\/80 in diabetes, chronic kidney disease, or established cardiovascular disease). Check resting pulse before each dose-increase \u2014 do not titrate if &lt;55 bpm.<\/p>\n<p><strong>Monitorizare:<\/strong><\/p>\n<ul>\n<li>Pulsul \u00een repaus \u0219i TA la 2, 4 \u0219i 8 s\u0103pt\u0103m\u00e2ni dup\u0103 \u00eenceperea tratamentului sau dup\u0103 modificarea dozei<\/li>\n<li>ECG de baz\u0103 dac\u0103 exist\u0103 antecedente cardiace; ECG periodic dac\u0103 apar modific\u0103ri ale simptomelor<\/li>\n<\/ul>\n<p><strong>Administrare:<\/strong> \u00eenghi\u021bi\u021bi comprimatul \u00eentreg cu ap\u0103. Lua\u021bi la aproximativ aceea\u0219i or\u0103 \u00een fiecare zi.<\/p>\n<p><strong>\u00centrerupere:<\/strong> <strong>NU \u00eentrerupe\u021bi brusc.<\/strong> Taper over 1-2 weeks (reduce by 25-50% every 3-5 days). Abrupt discontinuation causes rebound tachycardia, worsened angina, and \u2014 in patients with coronary disease \u2014 can precipitate myocardial infarction. This is one of the most important safety points for beta-blockers.<\/p>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p><strong>Frecvente (&gt;5%):<\/strong><\/p>\n<ul>\n<li><strong>Oboseal\u0103, letargie<\/strong> \u2014 often adapts over 2-4 weeks<\/li>\n<li><strong>M\u00e2ini \u0219i picioare reci<\/strong> (vasoconstric\u021bie periferic\u0103)<\/li>\n<li><strong>Bradicardie<\/strong> (verifica\u021bi pulsul; opri\u021bi dac\u0103 &lt;50 bpm)<\/li>\n<li><strong>Intoleran\u021b\u0103 la efort<\/strong> \u2014 maximum heart rate is blunted by beta blockade<\/li>\n<li>Ame\u021beli, hipotensiune postural\u0103<\/li>\n<li>Efecte asupra SNC sunt posibile, dar mai pu\u021bin frecvente dec\u00e2t cu propranolol<\/li>\n<li>Ameteli posturale (mai frecvente datorit\u0103 componentei vasodilatatoare)<\/li>\n<\/ul>\n<p><strong>Mai pu\u021bin frecvente:<\/strong> depresie, libido sc\u0103zut \/ disfunc\u021bie erectil\u0103, tulbur\u0103ri gastrointestinale, intoleran\u021b\u0103 la frig de tip Raynaud, bronhospasm (mai frecvent la agen\u021bii nespecifici).<\/p>\n<p><strong>Important dar neobi\u0219nuit:<\/strong><\/p>\n<ul>\n<li><strong>Hipoglicemie mascat\u0103 la diabetici<\/strong> \u2014 beta-blockers blunt the tachycardia \/ tremor warning signs of low blood sugar. Monitor glucose more carefully; prefer <a href=\"https:\/\/medsbase.com\/ro\/concor\/\">bisoprolol<\/a> la diabeticii trata\u021bi cu insulin\u0103.<\/li>\n<li><strong>Bronhospasm<\/strong> \u2014 can be severe in asthma \/ COPD. Absolute contraindication for non-selective agents; relative for cardioselective.<\/li>\n<li><strong>Bloc cardiac sau agravarea insuficien\u021bei cardiace<\/strong> \u2014 in susceptible patients. Start low, titrate slowly.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindica\u021bii \u0219i precau\u021bii<\/h2>\n<ul>\n<li><strong>Astm sever \/ BPOC sever<\/strong> \u2014 relative contraindication (cardioselectivity is relative, not absolute)<\/li>\n<li>Bloc atrioventricular de gradul doi sau trei (f\u0103r\u0103 stimulator cardiac)<\/li>\n<li>Bradicardie sinusal\u0103 &lt;50 bpm<\/li>\n<li>\u0218oc cardiogen, insuficien\u021b\u0103 cardiac\u0103 decompensat\u0103 care necesit\u0103 inotrope<\/li>\n<li>Boal\u0103 arterial\u0103 periferic\u0103 sever\u0103, sindromul Raynaud (relativ)<\/li>\n<li>Phaeochromocytoma without prior alpha-blockade \u2014 paradoxical hypertensive crisis (never use a beta-blocker before alpha-blocker)<\/li>\n<li>Insuficien\u021b\u0103 hepatic\u0103 sever\u0103 (pentru agen\u021bi metaboliza\u021bi extensiv hepatic: propranolol, metoprolol, carvedilol, labetalol)<\/li>\n<li>Severe renal impairment \u2014 dose adjustment needed for renal-excreted agents (atenolol, nadolol)<\/li>\n<li>Hipersensibilitate la nebivolol<\/li>\n<\/ul>\n<p><strong>Sarcina:<\/strong> Categoria C; trec prin placent\u0103; risc mic de restric\u021bie de cre\u0219tere intrauterin\u0103, bradicardie neonatal\u0103 \u0219i hipoglicemie. Utiliza\u021bi numai dac\u0103 beneficiul dep\u0103\u0219e\u0219te clar riscul; <a href=\"https:\/\/medsbase.com\/ro\/labebet\/\">labetalol<\/a> este beta-blocantul preferat \u00een sarcin\u0103.<\/p>\n<p><strong>Al\u0103ptarea:<\/strong> cantit\u0103\u021bi mici \u00een laptele matern; considerat \u00een general compatibil cu monitorizarea.<\/p>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<ul>\n<li><strong>Verapamil, diltiazem<\/strong> (non-dihydropyridine CCBs) \u2014 additive bradycardia, heart block, and negative inotropy; generally avoid combination. Dihydropyridine CCBs (<a href=\"https:\/\/medsbase.com\/ro\/amlode\/\">amlodipine<\/a>, nifedipin\u0103) sunt mai sigure de combinat cu beta-blocante.<\/li>\n<li><strong>Alte beta-blocante<\/strong> \u2014 do not combine; additive bradycardia<\/li>\n<li><strong>Clonidina<\/strong> \u2014 if stopping clonidine, stop the beta-blocker first (several days before) to avoid rebound hypertensive crisis<\/li>\n<li><strong>Insulin\u0103 \u0219i sulfoniluree<\/strong> \u2014 mask hypoglycaemia warning signs; monitor glucose closely<\/li>\n<li><strong>AINS<\/strong> \u2014 reduce the antihypertensive effect of beta-blockers; avoid chronic combination<\/li>\n<li><strong>Alcool<\/strong> \u2014 additive hypotension and CNS depression (particularly for lipophilic agents)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Beta-Blocante pe scurt<\/h2>\n<table style=\"width: 100%; border-collapse: collapse; margin: 14px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Beta-blocant<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Selectivitate<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Cel mai potrivit pentru<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/inderal\/\">Propranolol (Inderal, Ciplar, Beloc)<\/a><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Neselectiv<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Migren\u0103, tremor, tireotoxicoz\u0103, anxietate de performan\u021b\u0103, HTA<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/betablock-xl\/\">Metoprolol<\/a><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cardioselectiv<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Post-IM, IC-FER (succinat ER), angin\u0103, controlul frecven\u021bei \u00een FA<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/carvejohn\/\">Carvedilol<\/a><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Non-selective + \u03b1-1<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">IC-FER (dovezi de reducere a mortalit\u0103\u021bii), post-IM<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/concor\/\">Bisoprolol<\/a><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Foarte cardioselectiv<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">IC-FER, HTA, angin\u0103, controlul frecven\u021bei \u00een FA<\/td>\n<\/tr>\n<tr style=\"background: #fff3cd;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/nebicard\/\">Nebivolol<\/a><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ultra-selectiv + NO<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">V\u00e2rstnici, sindrom metabolic, disfunc\u021bie erectil\u0103<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/atenheal\/\">Atenolol<\/a><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cardioselectiv (hidrofil)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Angin\u0103, controlul frecven\u021bei \u00een fibrila\u021bia atrial\u0103 (linia a doua pentru HTA)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/labebet\/\">Labetalol<\/a><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Non-selective + \u03b1-1<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Hipertensiunea \u00een sarcin\u0103, criz\u0103 hipertensiv\u0103<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Beta-blocant preferat la pacien\u021bii v\u00e2rstnici, pacien\u021bii cu sindrom metabolic sau toleran\u021b\u0103 la glucoz\u0103 afectat\u0103, precum \u0219i la b\u0103rba\u021bii cu disfunc\u021bie erectil\u0103.<\/strong> Selectivitatea ultra-ridicat\u0103 pentru beta-1 \u00eenseamn\u0103 c\u0103 este \u00een general tolerat \u00een astmul u\u0219or p\u00e2n\u0103 la moderat (totu\u0219i nu absolut sigur; folosi\u021bi cu precau\u021bie \u0219i monitoriza\u021bi). Vasodilata\u021bia mediat\u0103 de NO \u00eei confer\u0103 un profil de sc\u0103dere a TA mai apropiat de un CCB dec\u00e2t de un beta-blocant clasic.<\/p>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<p>Store Nebicard below 25\u00b0C. Keep out of reach of children \u2014 accidental paediatric beta-blocker ingestion can cause life-threatening bradycardia and hypoglycaemia.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">C\u00e2t dureaz\u0103 p\u00e2n\u0103 Nebicard reduce tensiunea arterial\u0103?<\/h3>\n<p>Ve\u021bi observa o sc\u0103dere a TA \u00een 1-2 zile de la \u00eenceperea tratamentului; <strong>efectul antihipertensiv complet se ob\u021bine \u00een 2-4 s\u0103pt\u0103m\u00e2ni<\/strong> (datorat suprresiei graduale a sistemului renin\u0103-angiotensin\u0103, nu efectului imediat asupra frecven\u021bei cardiace). M\u0103sura\u021bi TA acas\u0103 la aceea\u0219i or\u0103 zilnic pentru a monitoriza r\u0103spunsul.<\/p>\n<h3 class=\"wp-block-heading\">Pot lua Nebicard dac\u0103 am astm?<\/h3>\n<p><strong>Nebivololul este ultra-selectiv + elibereaz\u0103 NO, deci este relativ mai sigur \u00een astm dec\u00e2t agen\u021bii non-selectivi.<\/strong> Cu toate acestea, cardioselectivitatea este <em>relativ\u0103<\/em> \u2014 at higher doses beta-2 blockade can still occur. In severe or brittle asthma, avoid all beta-blockers if possible. In mild asthma or COPD, use with monitoring and inhaler access.<\/p>\n<h3 class=\"wp-block-heading\">De ce nu ar trebui s\u0103 \u00eentrerup brusc tratamentul cu Nebicard?<\/h3>\n<p>\u00centreruperea brusc\u0103 provoac\u0103 <strong>tahicardie de rebond \u0219i agravarea anginei<\/strong> \u00een 24-48 de ore, datorit\u0103 supraregl\u0103rii receptorilor beta \u00een timpul blocadei cronice. La pacien\u021bii cu boal\u0103 coronarian\u0103, acest lucru poate precipita infarct miocardic sau angin\u0103 instabil\u0103. Reduce\u021bi progresiv doza pe parcursul a 1-2 s\u0103pt\u0103m\u00e2ni la \u00eentreruperea tratamentului.<\/p>\n<h3 class=\"wp-block-heading\">Nebicard \u00eemi va afecta performan\u021ba la exerci\u021bii fizice?<\/h3>\n<p>Yes \u2014 beta blockade blunts the heart-rate response to exercise, so your maximum pulse is lower and you fatigue faster at high intensities. For recreational exercise most people adapt; for competitive endurance athletes, beta-blockers can meaningfully impair performance and are banned in precision sports (shooting, archery \u2014 where they reduce physiological tremor).<\/p>\n<h3 class=\"wp-block-heading\">Nebicard \u00eemi va afecta nivelul de zah\u0103r din s\u00e2nge dac\u0103 am diabet?<\/h3>\n<p>Beta-blocante <strong>mascheaz\u0103 tahicardia\/tremorul\/palpita\u021biile care sunt semne de avertizare ale hipoglicemiei<\/strong>, f\u0103c\u00e2nd mai dificil\u0103 detectarea hipoglicemiei. De asemenea, pot atenua r\u0103spunsul contraregulator al glucozei. Monitoriza\u021bi glicemia mai frecvent \u00een timpul administr\u0103rii unui beta-blocant, \u00een special dac\u0103 lua\u021bi insulin\u0103 sau sulfoniluree. <a href=\"https:\/\/medsbase.com\/ro\/nebicard\/\">Nebivolol<\/a> \u0219i <a href=\"https:\/\/medsbase.com\/ro\/concor\/\">bisoprolol<\/a> au cel mai bun profil metabolic.<\/p>\n<h3 class=\"wp-block-heading\">Pot consuma alcool \u00een timpul tratamentului cu Nebicard?<\/h3>\n<p>Consumul moderat de alcool este \u00een general acceptabil, dar alcoolul poten\u021beaz\u0103 efectele hipotensive \u0219i deprimante ale SNC. Ridica\u021bi-v\u0103 \u00eencet dup\u0103 consum. Alcoolul este \u0219i un factor independent care cre\u0219te TA; reducerea consumului poate \u00eembun\u0103t\u0103\u021bi controlul TA independent de Nebicard.<\/p>\n<h3 class=\"wp-block-heading\">Nebicard provoac\u0103 cre\u0219tere \u00een greutate?<\/h3>\n<p>Beta-blocantele mai vechi (propranolol, atenolol, metoprolol) sunt asociate cu o cre\u0219tere modest\u0103 a greut\u0103\u021bii (1-3 kg) \u0219i cu o \u00eenr\u0103ut\u0103\u021bire a sensibilit\u0103\u021bii la insulin\u0103 \u00een timp. <strong>Nebivololul \u0219i carvedilolul sunt neutre din punct de vedere al greut\u0103\u021bii sau u\u0219or favorabile<\/strong> datorit\u0103 componentelor lor vasodilatatoare. Pentru pacien\u021bii cu sindrom metabolic, <a href=\"https:\/\/medsbase.com\/ro\/nebicard\/\">nebivolol<\/a> este beta-blocantul preferat atunci c\u00e2nd este necesar.<\/p>\n<h3 class=\"wp-block-heading\">Nebicard este sigur \u00een timpul sarcinii?<\/h3>\n<p>Categoria C. Folosi\u021bi doar dac\u0103 beneficiul dep\u0103\u0219e\u0219te clar riscul. Pentru utilizarea antihipertensiv\u0103 \u00een sarcin\u0103, <a href=\"https:\/\/medsbase.com\/ro\/labebet\/\">labetalol<\/a> este beta-blocantul preferat; metildopa \u0219i nifedipina sunt celelalte dou\u0103 op\u021biuni sigure \u00een sarcin\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Pot lua Nebicard \u00eempreun\u0103 cu alte medicamente pentru TA?<\/h3>\n<p>Yes \u2014 beta-blockers combine well with <strong>blocantele ale canalelor de calciu dihidropiridinice<\/strong> (<a href=\"https:\/\/medsbase.com\/ro\/amlode\/\">amlodipine<\/a>), <strong>Inhibitori ACE<\/strong> (ramipril, lisinopril), <strong>BRA<\/strong> (<a href=\"https:\/\/medsbase.com\/ro\/losar\/\">losartan<\/a>, <a href=\"https:\/\/medsbase.com\/ro\/telmaheal\/\">telmisartan<\/a>, <a href=\"https:\/\/medsbase.com\/ro\/olmin\/\">olmesartan<\/a>), \u0219i <strong>diuretice tiazidice<\/strong> (<a href=\"https:\/\/medsbase.com\/ro\/aquazide\/\">HCTZ<\/a>). <strong>Evita\u021bi combina\u021bia cu antagoni\u0219ti calcici non-dihidropiridinici<\/strong> (verapamil, diltiazem) \u2014 additive bradycardia and heart-block risk.<\/p>\n<h3 class=\"wp-block-heading\">Unde pot cump\u0103ra Nebicard online?<\/h3>\n<p>Pute\u021bi cump\u0103ra Nebicard (nebivolol 2,5 mg \/ 5 mg comprimat, 30-180 comprimate) de la MedsBase cu ambalaj discret \u0219i livrare la nivel mondial.<\/p>\n<h2 class=\"wp-block-heading\">Beta-Blocante \u0219i Antihipertensive Asem\u0103n\u0103toare<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/beloc\/\">Beloc \u2014 Propranolol 10\/20\/40 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/carloc\/\">Carloc \u2014 Carvedilol 3.125 mg (HF starter)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/ciplar\/\">Ciplar \u2014 Propranolol 10 mg (Cipla)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/inderal\/\">Inderal \u2014 Propranolol IR 20\/40 mg (AstraZeneca)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/p-nolol-sr\/\">P-Nolol SR \u2014 Propranolol 80 mg sustained-release<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/provanol-sr\/\">Provanol SR \u2014 Propranolol 80 mg SR<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/high-blood-pressure-medication\/\"><strong>R\u0103sfoi\u021bi toate medicamentele pentru hipertensiune arterial\u0103<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background: #fff3f3; border-left: 4px solid #d9534f; padding: 16px 20px; margin: 24px 0; border-radius: 4px;\"><strong>\u2695 Medical Disclaimer.<\/strong> This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Hypertension, heart failure, and arrhythmias require diagnosis, monitoring, and dose individualisation by a doctor \u2014 always use beta-blockers under medical guidance.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/voritrol\/\">Voritrol<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/flexabenz-er\/\">Flexabenz ER<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/rofaday\/\">Rofaday<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/doxolin\/\">Doxolin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tofe\/\">Tofe<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Nebicard este comprimat de nebivolol 2,5\/5 mg de la Torrent \u2014 beta-blocant ultra-selectiv cu vasodilata\u021bie mediat\u0103 de oxid nitric. Beta-blocant preferat la pacien\u021bii v\u00e2rstnici, cu sindrom metabolic sau disfunc\u021bie erectil\u0103. Pentru hipertensiune (5-10 mg o dat\u0103 pe zi) \u0219i insuficien\u021b\u0103 cardiac\u0103 la v\u00e2rstnici. Profil metabolic superior fa\u021b\u0103 de atenolol\/metoprolol.<\/p>","protected":false},"featured_media":51813,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[3415,3416],"class_list":{"0":"post-51812","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_cat-high-blood-pressure-medication","10":"product_tag-nebicard","11":"product_tag-nebivolol","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/51812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=51812"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/51813"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=51812"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=51812"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=51812"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=51812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}